BACKGROUND: Shared decision-making is an important component of patient-centered care and is associated with improved outcomes. To the authors' knowledge, little is known concerning the extent and predictors of the involvement of a patient's family in decisions regarding cancer treatments. METHODS: The Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium is a large, multiregional, prospective cohort study of the cancer care and outcomes of patients with lung and colorectal cancer. Participants reported the roles of their families in decision-making regarding treatment. Multinomial logistic regression was used to assess patient factors associated with family roles in decisions. RESULTS: Among 5284 patients, 80 (1.5%) reported family-controlled decisions, with the highest adjusted rates (12.8%) noted among non-English-speaking Asians. Among the 5204 remaining patients, 49.4% reported equally sharing decisions with family, 22.1% reported some family input, and 28.5% reported little family input. In adjusted analyses, patients who were married, female, older, and insured more often reported equally shared decisions with family (all P <.001). Adjusted family involvement varied by race/ethnicity and language, with Chinese-speaking Asian (59.8%) and Spanish-speaking Hispanic (54.8%) patients equally sharing decisions with family more often than white individuals (47.6%). Veterans Affairs patients were least likely to report sharing decisions with family, even after adjustment for marital status and social support (P <.001). CONCLUSIONS: The majority of patients with newly diagnosed lung or colorectal cancer involve family members in treatment decisions. Non-English-speaking Asians and Hispanics rely significantly on family. Further studies are needed to determine the impact of family involvement in treatment decisions on outcomes; until then, physicians should consider eliciting patients' preferences for family involvement.
BACKGROUND: Shared decision-making is an important component of patient-centered care and is associated with improved outcomes. To the authors' knowledge, little is known concerning the extent and predictors of the involvement of a patient's family in decisions regarding cancer treatments. METHODS: The Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium is a large, multiregional, prospective cohort study of the cancer care and outcomes of patients with lung and colorectal cancer. Participants reported the roles of their families in decision-making regarding treatment. Multinomial logistic regression was used to assess patient factors associated with family roles in decisions. RESULTS: Among 5284 patients, 80 (1.5%) reported family-controlled decisions, with the highest adjusted rates (12.8%) noted among non-English-speaking Asians. Among the 5204 remaining patients, 49.4% reported equally sharing decisions with family, 22.1% reported some family input, and 28.5% reported little family input. In adjusted analyses, patients who were married, female, older, and insured more often reported equally shared decisions with family (all P <.001). Adjusted family involvement varied by race/ethnicity and language, with Chinese-speaking Asian (59.8%) and Spanish-speaking Hispanic (54.8%) patients equally sharing decisions with family more often than white individuals (47.6%). Veterans Affairs patients were least likely to report sharing decisions with family, even after adjustment for marital status and social support (P <.001). CONCLUSIONS: The majority of patients with newly diagnosed lung or colorectal cancer involve family members in treatment decisions. Non-English-speaking Asians and Hispanics rely significantly on family. Further studies are needed to determine the impact of family involvement in treatment decisions on outcomes; until then, physicians should consider eliciting patients' preferences for family involvement.
Authors: Jennifer L Malin; Clifford Ko; John Z Ayanian; David Harrington; David R Nerenz; Katherine L Kahn; Julie Ganther-Urmie; Paul J Catalano; Alan M Zaslavsky; Robert B Wallace; Edward Guadagnoli; Neeraj K Arora; Maryse D Roudier; Patricia A Ganz Journal: Support Care Cancer Date: 2006-02-16 Impact factor: 3.603
Authors: Sarah T Hawley; Jennifer J Griggs; Ann S Hamilton; John J Graff; Nancy K Janz; Monica Morrow; Reshma Jagsi; Barbara Salem; Steven J Katz Journal: J Natl Cancer Inst Date: 2009-08-31 Impact factor: 13.506
Authors: Jennifer L Wolff; Yue Guan; Cynthia M Boyd; Judith Vick; Halima Amjad; David L Roth; Laura N Gitlin; Debra L Roter Journal: Patient Educ Couns Date: 2016-10-25
Authors: Elizabeth Flood-Grady; Jordan M Neil; Samantha R Paige; Donghee Lee; Rachel E Damiani; Deaven Hough; Zack Savitsky; Thomas J George; Janice L Krieger Journal: J Cancer Educ Date: 2020-06 Impact factor: 2.037
Authors: J Nicholas Dionne-Odom; Rachel D Wells; Kate Guastaferro; Andres Azuero; Bailey A Hendricks; Erin R Currie; Avery Bechthold; Chinara Dosse; Richard Taylor; Rhiannon D Reed; Erin R Harrell; Shena Gazaway; Sally Engler; Peg McKie; Grant R Williams; Rebecca Sudore; Christine Rini; Abby R Rosenberg; Marie A Bakitas Journal: J Pain Symptom Manage Date: 2021-07-31 Impact factor: 3.612
Authors: Joaquin Michel; Jorge Ballon; Sarah E Connor; David C Johnson; Jonathan Bergman; Christopher S Saigal; Mark S Litwin; Dana L Alden Journal: MDM Policy Pract Date: 2021-05-27